Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Jul 2020;18(3):e101776
Additionally, chronic supplementation has shown potential in ameliorating factors associated with metabolic syndrome and cardiovascular disease, such as arterial hypertension and impaired glucose tolerance.[13] A systematic review and meta-analysis further supports these findings, revealing that L-carnitine supplementation at doses of 13 g/day significantly reduced waist circumference, systolic blood pressure, fasting blood sugar, and triglycerides, while also increasing HDL cholesterol
The individual components of KLOW have been studied extensively in research settings with favorable safety profiles
Spiering BA, Kraemer WJ, Hatfield DL, Vingren JL, Fragala MS, Ho JY, Thomas GA, Hakkinen K, Volek JS
"Incretin-based glucose-lowering medications and the risk of acute pancreatitis and malignancies: a meta-analysis based on cardiovascular outcomes trials"
ipharmapharmacy.com 6PubMed (March 4, 2026)
US$ 28.90
US$ 21.79
US$ 25.36
US$ 22.29
US$ 29.39
US$ 22.77
US$ 24.72
